Patent · US Active

Nano-fibular nanoparticle polymer-drug conjugate for sustained dermal delivery of retinoids

US11590240B2 · kind B2 · utility

0Cited by
2References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2016
Grant dateFeb 28, 2023
Priority date
Expiry dateJun 23, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are conjugated polymers comprising a polymer and an all-trans retinoic acid (ATRA) prodrug covalently bound to the polymer by a hydrolysable linker L or a pharmaceutically acceptable salt thereof, and methods of using same to treat certain disorders. In an embodiment, the conjugated polymer comprises poly (vinyl alcohol) covalently bound to ATRA through an ester linkage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.